Frame Bio

Frame Bio

Pre-clinical
San Francisco, United StatesFounded 2021frame.bio

Developing next-gen therapies for bone and connective tissue disorders that target root causes using a natural form of intercellular drug delivery.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Funding information not available

About

Developing next-gen therapies for bone and connective tissue disorders that target root causes using a natural form of intercellular drug delivery.

Drug Delivery